We are live on
!
Find out more
BFM
Boston Financial Management Portfolio holdings
AUM
$3.31B
1-Year Est. Return
19.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$648M
AUM Growth
–
Cap. Flow
+$656M
Cap. Flow
% of AUM
101.29%
Top 10 Holdings %
Top 10 Hldgs %
30.29%
Holding
199
New
199
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$67M |
| 2 |
ExxonMobil
XOM
|
+$23M |
| 3 |
IBM
IBM
|
+$21.7M |
| 4 |
Johnson & Johnson
JNJ
|
+$15.5M |
| 5 |
Procter & Gamble
PG
|
+$14M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.15% |
| 2 | Consumer Staples | 11.73% |
| 3 | Energy | 11.08% |
| 4 | Technology | 10.95% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Danaher
DHR
$139B
| $3.96M | 0.61% |
+92,998
| New | +$3.85M |
|
52
Devon Energy
DVN
$51.1B
| $3.94M | 0.61% |
+76,003
| New | +$4.23M |
|
|
MMP
53
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $3.83M | 0.59% |
+70,345
| New | +$3.69M |
|
|
PX
54
DELISTED
Praxair Inc
PX
| $3.83M | 0.59% |
+33,248
| New | +$3.79M |
|
|
NVO
55
Novo Nordisk
NVO
$209B
| $3.66M | 0.56% |
+235,990
| New | +$3.93M |
|
56
AvalonBay Communities
AVB
$26.7B
| $3.6M | 0.56% |
+26,645
| New | +$3.56M |
|
57
Berkshire Hathaway Class B
BRK.B
$1.1T
| $3.56M | 0.55% |
+31,800
| New | +$3.5M |
|
58
Cisco
CSCO
$455B
| $3.41M | 0.53% |
+140,204
| New | +$3.15M |
|
59
Colgate-Palmolive
CL
$72.8B
| $3.41M | 0.53% |
+59,469
| New | +$3.53M |
|
60
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
| $3.33M | 0.51% |
+77,268
| New | +$3.72M |
|
61
Home Depot
HD
$330B
| $3.32M | 0.51% |
+42,842
| New | +$3.22M |
|
62
iShares MSCI Emerging Markets ETF
EEM
$29.2B
| $3.27M | 0.51% |
+85,028
| New | +$3.53M |
|
63
Visa
V
$674B
| $3.16M | 0.49% |
+69,132
| New | +$3.03M |
|
64
Public Storage
PSA
$59.4B
| $3.07M | 0.47% |
+20,033
| New | +$3.16M |
|
65
Stryker
SYK
$128B
| $2.99M | 0.46% |
+46,279
| New | +$3.07M |
|
66
Amgen
AMGN
$206B
| $2.98M | 0.46% |
+30,209
| New | +$3.13M |
|
|
CERN
67
DELISTED
Cerner Corp
CERN
| $2.96M | 0.46% |
+61,622
| New | +$2.95M |
|
|
KMP
68
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| $2.89M | 0.45% |
+33,819
| New | +$2.94M |
|
69
Medtronic
MDT
$108B
| $2.87M | 0.44% |
+55,844
| New | +$2.76M |
|
|
MON
70
DELISTED
Monsanto Co
MON
| $2.76M | 0.43% |
+27,962
| New | +$2.93M |
|
71
Plains All American Pipeline
PAA
$17.2B
| $2.75M | 0.42% |
+49,252
| New | +$2.79M |
|
72
Philip Morris
PM
$297B
| $2.69M | 0.42% |
+31,084
| New | +$2.89M |
|
73
Oracle
ORCL
$379B
| $2.63M | 0.41% |
+85,800
| New | +$2.85M |
|
74
Vanguard Dividend Appreciation ETF
VIG
$111B
| $2.62M | 0.4% |
+39,515
| New | +$2.65M |
|
75
McCormick & Company Non-Voting
MKC
$13.6B
| $2.6M | 0.4% |
+73,938
| New | +$2.66M |
|
Similar funds
CANY
MWM
CCM
ECG
LSAG
KL
WP
RDIA
Boston Financial Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Boston Financial Management, which disclosed 199 positions worth $648M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Pfizer: 2,424,540 shares worth $64.4M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Consumer Staples and Energy.
- Boston Financial Management's largest Q2 2013 buy was Pfizer: 2,424,540 shares worth $64.4M.
- Boston Financial Management's ten largest holdings make up 30% of its $648M portfolio in Q2 2013.
- Boston Financial Management disclosed 199 positions in Q2 2013, its first 13F filing on record.
Based on Boston Financial Management's 13F filing for Q2 2013, filed 19 Aug 2013.